A Florida jury has concluded that Johnson & Johnson's baby powder talc product did not cause the ovarian cancer of a Florida woman who died in 2019. The lawsuit was brought by family members of Patricia Matthey, who used Johnson's baby powder daily from 1965 until August 2016, when she was diagnosed with ovarian cancer. Johnson & Johnson's worldwide vice president of litigation Erik Haas said the company was vindicated by the jury's decision.

BIG WIN FOR J&J: Talc didn't cause ovarian cancer of Florida litigant: Court

U.S. Consumer Product giant Johnson & Johnson has reached a tentative settlement to resolve probes by u.S. States. Several states are probing whether the company misled consumers about the safety of its talc products. As part of the deal, which includes 42 states and Washington, D.C., the company has agreed to pay about $700 million to settle the state's claims.

Johnson & Johnson's tentative deal to end probes by states

Johnson & Johnson will stop selling talc-based baby powder globally in 2023, the drug maker said on Thursday, more than two years after it ended US sales of a product that drew thousands of consumer safety lawsuits.

Johnson & Johnson to end global sales of talc-based baby powder

Johnson & Johnson to end global sales of controversial talc-based baby powder

talc

Talc, News on Talc, stories on Talc, articles on Talc, Talc stories at Wion, Talc news, Talc latest news